 Home > Medical News > Latest Medical News > China's first RET inhibitor, Cornerstone Pharmaceuticals, pratinib approved

China's first RET inhibitor, Cornerstone Pharmaceuticals, pratinib approved

 Last Update: 2021-04-27
 Source: Internet
 Author: User

Tags

burkholderia cepacia treatment

drug test ghb

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CStone Pharmaceuticals announced today that NMPA has approved the marketing application of pratinib capsules for locally advanced or metastatic non-small cell lung cancer (NSCLC) that has previously received platinum-containing chemotherapy for transfection rearrangement (RET) gene fusion-positive non-small cell lung cancer (NSCLC) Treatment of adult patients.

According to public information, the indication for the drug in this application is an adult patient with locally advanced or metastatic non-small cell lung cancer (NSCLC) who has previously received platinum-containing chemotherapy and has a positive RET gene fusion.

Pratinib is a potent and selective RET inhibitor developed by Blueprint Medicines under the trade name GAVRETO™.

Organized from: CStone Pharmaceutical's official website

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.